Natco Pharma jumped 6.2% to Rs 884.35 after the company received final approval for everolimus tablets in the US market.Natco Pharma announced that its marketing partner, Breckenridge Pharmaceutical Inc. (BPI), has received final approval for its abbreviated new drug application (ANDA) for everolimus tablets (a generic version of Afinitor) from the US Food and Drug Administration (USFDA).
BPI plans to launch 2.5 mg, 5 mg and 7.5 mg strengths of the product shortly within the next few weeks. The launch of 10mg strength of the product is subject to confidential terms of a settlement and license agreement entered into with the owner of the Afinitor brand. The launch date of 10mg strength of the product will be announced at a later date.
Maruti Suzuki India said the company produced total 1,68,180 vehicles in February 2021 as against 1,40,933 vehicles in February 2020.
The board of directors of Adani Ports and Special Economic Zone (APSEZ) approved to issue up to 1 crore equity shares to Windy Lakeside Investment (Windy) at a price of Rs 800 per equity share, for an aggregate consideration of up to Rs 800 crore.
Cipla (UK), a wholly owned subsidiary of Cipla (EU) and a wholly owned step down subsidiary of Cipla, has been voluntarily liquidated with effect from 5th March, 2021. This liquidation was a part of internal reorganisation and it will not affect performance or revenue of the company.
Amber Enterprises India Ltd notched up volume of 1.14 lakh shares by 10:48 IST on BSE, a 5.3 fold spurt over two-week average daily volume of 21603 shares
Grindwell Norton Ltd, IRB Infrastructure Developers Ltd, Natco Pharma Ltd, Shriram City Union Finance Ltd are among the other stocks to see a surge in volumes on BSE today, 08 March 2021.
Amber Enterprises India Ltd notched up volume of 1.14 lakh shares by 10:48 IST on BSE, a 5.3 fold spurt over two-week average daily volume of 21603 shares. The stock rose 3.08% to Rs.3,556.80. Volumes stood at 95182 shares in the last session.
Grindwell Norton Ltd notched up volume of 12901 shares by 10:48 IST on BSE, a 3.87 fold spurt over two-week average daily volume of 3333 shares. The stock rose 7.01% to Rs.965.85. Volumes stood at 2244 shares in the last session.
Read more about Sensex ends almost flat, Nifty ends below 15,000; PSU banks, metal stocks advance on Business Standard. Domestic equity market started on a strong note, but gave up all gains during the latter half of the day. PSU banks, metals and pharma stocks advanced while autos, financials and FMCG shares declined. The barometer index, the S&P BSE Sensex, rose
Aarti Speciality Chemicals, a wholly-owned subsidiary of Aarti Drugs (Aarti Drugs), stands out to be one of the beneficiaries of the Government of India s recently approved Production Linked Incentive (PLI) for the Pharmaceutical Sector.
Government of India s Department of Pharmaceuticals under the Ministry of Chemicals and Fertilizers recently launched a Production Linked Incentive (PLI) Scheme to promote domestic manufacturing by incentivising pharmaceutical manufacturers to set-up greenfield projects in India with a minimum domestic value addition in four different target segments (Two in Fermentation based - at least 90% and Two in the Chemical Synthesis based - at least 70%) with a total outlay of Rs. 6,940 crores. The objective of the scheme is achieving self-reliance and reducing import dependence in these critical Key Starting Materials (KSMs)/ Drug Intermediates/ Active Pharmaceutical Ingredients (APIs) in the country.